Answer
Nasolacrimal occlusion or gentle eyelid closure after administering Alomide (lodoxamide trometamol) eye drops is recommended because it may reduce systemic absorption and thereby decrease systemic adverse reactions.
Sources for this answer
- ALOMIDE 0.1% w/vNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 9Document updated
Sources checked